[Imidazoline receptors and use of drug blocking receptors I1].
Imidazoline-preferring receptors are important in the pathophysiology of hypertension. The selective l1-receptor agonists are moxonidine, cimetidine and rilmenidine. Some clinical studies indicate the usefulness of moxonidine therapy in hypertension, arrhythmias and acute myocardial infarction.
Lada
W
W
Katedry i Kliniki Kardiologii AM w Warszawie, Szpital Bródnowski.
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002927:Cimetidine / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D010080:Oxazoles / Q000627:therapeutic use; D000077769:Rilmenidine
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D010080:Oxazoles; D002927:Cimetidine; C043482:moxonidine; D000077769:Rilmenidine
Receptory imidazolinowe i stosowanie leków blokujacych receptory l1.